| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Scientific Officer,Svp-r& D | Chief Scientific Officer,Svp-r& D | Sr Vp-research & Development +1 more
1 company
Frederique Ph.D. Menzaghi last filed a Form 4 in February 2024, as Chief Scientific Officer,Svp-r& D at TVRD. From March 2015 to February 2024, the filings on record show 0 open-market purchases and 45 sales. Frederique Ph.D. Menzaghi's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
Our model assigns Frederique Ph.D. Menzaghi a strong insider score of 85/100, based on 7 past trades. Over a 12-month horizon, all 7 of those trades were profitable, with an average 12-month return of +64.8%.
At the last filing, the largest reported position was 167,247 shares of TVRD. The TVRD filings lean toward selling, a net 283,239 shares.
Shares as reported in the last Form 4 for each company; the most recent is from February 2024. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Nov 2, 2015 | TVRD Tvardi Therapeutics, Inc. | Vp-research & Development | Sell | 6,000 | $14.26 | $85,560.00 | -3.9% | |
| Oct 1, 2015 | TVRD Tvardi Therapeutics, Inc. | Vp-research & Development | Sell | 6,000 | $13.95 | $83,715.00 | -3.8% | |
| Sep 1, 2015 | TVRD Tvardi Therapeutics, Inc. | Vp-research & Development | Sell | 7,000 | $18.63 | $130,410.00 | -4.2% | |
| Aug 3, 2015 | TVRD Tvardi Therapeutics, Inc. | Vp-research & Development | Sell | 7,000 | $21.41 | $149,870.00 | -4.0% | |
| Jul 1, 2015 | TVRD Tvardi Therapeutics, Inc. | Vp-research & Development | Sell | 7,000 | $12.22 | $85,540.00 | -3.9% |